Patents by Inventor Giovanni Bussolati

Giovanni Bussolati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230017439
    Abstract: The invention relates to a method of preservation of nucleic acid sequences in histological tissues which comprises: treating a concentrated formaldehyde solution in water with basic ion-exchange resins; diluting the resulting acid-deprived formaldehyde solution with phosphate buffer pH 7.2-7.4 up to a concentration ranging between 2 and 4%; contacting the resulting acid-deprived formaldehyde solution obtained with the tissue samples; optionally embedding the samples fixed in paraffin.
    Type: Application
    Filed: December 15, 2020
    Publication date: January 19, 2023
    Applicant: ADDAX BIOSCIENCES S.R.L.
    Inventors: Giovanni Bussolati, Benedetta Bussolati, Nicolo' Bussolati
  • Patent number: 11204305
    Abstract: The invention refers to a composition for the fixation of histological preparations, comprising a solution of glyoxal, wherefrom acids, normally present in the commercially available glyoxal, have been removed. The composition of the invention provides an optimal fixative for the preservation of structure, antigenic components and nucleic acids in tissues. The acid-free glyoxal has limited toxicity, is not considered as a carcinogenic agent and represents a valid alternative to formalin for the fixation of tissues and cells.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: December 21, 2021
    Assignee: ADDAX BIOSCIENCES S.R.L.
    Inventor: Giovanni Bussolati
  • Publication number: 20190049348
    Abstract: The invention refers to a composition for the fixation of histological preparations, comprising a solution of glyoxal, wherefrom acids, normally present in the commercially available glyoxal, have been removed. The composition of the invention provides an optimal fixative for the preservation of structure, antigenic components and nucleic acids in tissues. The acid-free glyoxal has limited toxicity, is not considered as a carcinogenic agent and represents a valid alternative to formalin for the fixation of tissues and cells.
    Type: Application
    Filed: February 10, 2017
    Publication date: February 14, 2019
    Applicant: ADDAX BIOSCIENCES S.R.L.
    Inventor: Giovanni Bussolati
  • Patent number: 9955953
    Abstract: The invention refers to a container (1) for collecting, transporting and storing biological tissue samples, wherein the container (1) is filled with a first component (3) being a fixative and a second component (4) being a fluid, wherein the second component (3) has a lower specific gravity compared to the fixative (3), and is immiscible with the fixative (3). The second component (4) is stratified on top of the fixative (3) to form a protective film to prevent fixative fumes to escape from the container (1). The invention further relates to a method for collecting, transporting and storing biological tissue samples.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: May 1, 2018
    Assignee: Milestone S.r.l.
    Inventors: Francesco Visinoni, Marco Bellini, Giovanni Bussolati, Michele Martinelli
  • Publication number: 20160157837
    Abstract: The invention refers to a container (1) for collecting, transporting and storing biological tissue samples, wherein the container (1) is filled with a first component (3) being a fixative and a second component (4) being a fluid, wherein the second component (3) has a lower specific gravity compared to the fixative (3), and is immiscible with the fixative (3). The second component (4) is stratified on top of the fixative (3) to form a protective film to prevent fixative fumes to escape from the container (1). The invention further relates to a method for collecting, transporting and storing biological tissue samples.
    Type: Application
    Filed: April 15, 2015
    Publication date: June 9, 2016
    Inventors: Francesco Visinoni, Marco Bellini, Giovanni Bussolati, Michele Martinelli
  • Patent number: 8110346
    Abstract: A process for preserving tissues is described which comprises transferring the tissues in a container and evacuating the container.
    Type: Grant
    Filed: December 9, 2008
    Date of Patent: February 7, 2012
    Assignee: Milestone S.r.l.
    Inventor: Giovanni Bussolati
  • Publication number: 20090191533
    Abstract: A process for preserving tissues is described which comprises transferring the tissues in a container and evacuating the container.
    Type: Application
    Filed: December 9, 2008
    Publication date: July 30, 2009
    Applicant: Milestone S.r.l.
    Inventor: Giovanni Bussolati
  • Publication number: 20040110239
    Abstract: The present invention involves the localization of HER2 receptor (extra-cellular domain) in breast cancer cells, using a humanized monoclonal antibody. The invention is related to a modification of the Herceptin antibody, so as to maintain the antibody properties, while making the antibody directly recognizable in immunohistochemistry.
    Type: Application
    Filed: April 17, 2003
    Publication date: June 10, 2004
    Applicant: BIOTHER di Contardi Gabriella & C. Societa in accomandita semplice
    Inventors: Giovanni Bussolati, Anna Sapino